Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

Renal Stones/Calculi Global Clinical Trials Review, H2, 2019

Published by GlobalData Product code 326153
Published Content info 225 Pages
Delivery time: 1-2 business days
Price
Back to Top
Renal Stones/Calculi Global Clinical Trials Review, H2, 2019
Published: December 19, 2019 Content info: 225 Pages
Description

GlobalData's clinical trial report, "Renal Stones/Calculi Global Clinical Trials Review, H2, 2019" provides an overview of Renal Stones/Calculi clinical trials scenario. This report provides top line data relating to the clinical trials on Renal Stones/Calculi. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents
Product Code: GDHC5214CTIDB

Table of Contents

  • List of Tables 4
  • List of Figures 5
  • Report Guidance 6
  • GlobalData Clinical Trials Report Coverage 7
  • Clinical Trials by Region 8
  • Clinical Trials and Average Enrollment by Country 9
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
  • Top Five Countries Contributing to Clinical Trials in Europe 13
  • Top Countries Contributing to Clinical Trials in North America 14
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15
  • Top Countries Contributing to Clinical Trials in Central and South America 16
  • Clinical Trials by G7 Countries: Proportion of Renal Stones/Calculi to Genito Urinary System And Sex Hormones Clinical Trials 17
  • Clinical Trials by Phase in G7 Countries 19
  • Clinical Trials in G7 Countries by Trial Status 20
  • Clinical Trials by E7 Countries: Proportion of Renal Stones/Calculi to Genito Urinary System And Sex Hormones Clinical Trials 22
  • Clinical Trials by Phase in E7 Countries 24
  • Clinical Trials in E7 Countries by Trial Status 25
  • Clinical Trials by Phase 27
  • In Progress Trials by Phase 28
  • Clinical Trials by Trial Status 29
  • Clinical Trials by End Point Status 31
  • Subjects Recruited Over a Period of Time 32
  • Clinical Trials by Sponsor Type 33
  • Prominent Sponsors 34
  • Top Companies Participating in Renal Stones/Calculi Therapeutics Clinical Trials 36
  • Prominent Drugs 38
  • Clinical Trial Profile Snapshots 39

Appendix 227

  • Abbreviations 227
  • Definitions 227
  • Research Methodology 228
  • Secondary Research 228
  • About GlobalData 229
  • Contact Us 229
  • Source 230

List of Tables

  • Renal Stones/Calculi Therapeutics, Global, Clinical Trials by Region, 2019* 8
  • Renal Stones/Calculi Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 10
  • Renal Stones/Calculi Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 11
  • Renal Stones/Calculi Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2019* 12
  • Renal Stones/Calculi Therapeutics Clinical Trials, Europe, Top Five Countries, 2019* 13
  • Renal Stones/Calculi Therapeutics Clinical Trials, North America, Top Countries, 2019* 14
  • Renal Stones/Calculi Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2019* 15
  • Renal Stones/Calculi Therapeutics Clinical Trials, Central and South America, Top Countries, 2019* 16
  • Proportion of Renal Stones/Calculi to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2019* 18
  • Renal Stones/Calculi Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 19
  • Renal Stones/Calculi Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 21
  • Proportion of Renal Stones/Calculi to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2019* 23
  • Renal Stones/Calculi Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 24
  • Renal Stones/Calculi Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 26
  • Renal Stones/Calculi Therapeutics, Global, Clinical Trials by Phase, 2019* 27
  • Renal Stones/Calculi Therapeutics, Global, Clinical Trials In Progress by Phase 2019* 28
  • Renal Stones/Calculi Therapeutics, Global, Clinical Trials by Trial Status, 2019* 30
  • Renal Stones/Calculi Therapeutics Clinical Trials, Global, by End Point Status, 2019* 31
  • Renal Stones/Calculi Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 32
  • Renal Stones/Calculi Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2019* 33
  • Renal Stones/Calculi Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 35
  • Renal Stones/Calculi Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 37
  • Renal Stones/Calculi Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 38

List of Figures

  • Renal Stones/Calculi Therapeutics, Global, Clinical Trials by Region (%), 2019* 8
  • Renal Stones/Calculi Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 9
  • Renal Stones/Calculi Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 11
  • Renal Stones/Calculi Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2019* 12
  • Renal Stones/Calculi Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2019* 13
  • Renal Stones/Calculi Therapeutics Clinical Trials, North America, Top Countries (%), 2019* 14
  • Renal Stones/Calculi Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2019* 15
  • Renal Stones/Calculi Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2019* 16
  • Proportion of Renal Stones/Calculi to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2019* 17
  • Renal Stones/Calculi Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 19
  • Renal Stones/Calculi Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 20
  • Proportion of Renal Stones/Calculi to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2019* 22
  • Renal Stones/Calculi Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 24
  • Renal Stones/Calculi Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 25
  • Renal Stones/Calculi Therapeutics, Global, Clinical Trials by Phase (%), 2019* 27
  • Renal Stones/Calculi Therapeutics, Global, Clinical Trials In Progress by Phase, 2019* 28
  • Renal Stones/Calculi Therapeutics, Global, Clinical Trials by Trial Status, 2019* 29
  • Renal Stones/Calculi Therapeutics Clinical Trials, Global, by End Point Status, 2019* 31
  • Renal Stones/Calculi Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 32
  • Renal Stones/Calculi Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2019* 33
  • Renal Stones/Calculi Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 34
  • Renal Stones/Calculi Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 36
  • Renal Stones/Calculi Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 38
  • GlobalData Methodology 228
Back to Top